Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.94 USD | -0.22% | -0.92% | -14.63% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.63% | 89.27B | |
+33.01% | 700B | |
-4.97% | 358B | |
+19.11% | 330B | |
+3.43% | 287B | |
+16.26% | 236B | |
+6.68% | 202B | |
-9.20% | 197B | |
+5.57% | 161B | |
-2.95% | 157B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol-Myers Squibb Says European Regulator Recommends Approval of Bladder Cancer Combination Therapy